Prof Stephen Jan is Director of Health Systems Science at the George Institute for Global Health, Conjoint Professor of Health Economics at the University of New South Wales, and Professor of Health Systems at Imperial College London. He holds Adjunct Professorships at City University of Hong Kong and Walter Sisulu University in South Africa and is a Fellow of the Australian Academy of Health and Medical Sciences. His areas of expertise are health systems, economic evaluation, health financing, choice experiments and health sector priority setting.

Martin is Professorial Fellow at the George Institute, Head of the South Western Sydney Campus for the Faculty of Medicine & Health at UNSW, and a clinical nephrologist at Liverpool Hospital.

He has worked extensively within the ANZ Society of Nephrology in renal guidelines, clinical policy and research.

Martin’s research interests include large scale clinical trials to explore ways to improve the outcomes of patients with kidney disease (esp in the setting of acute kidney injury), measurement of health systems and applying research evidence into clinical practice.

Dr. Soumyadeep Bhaumik is a medical doctor and international public health research methodologist striving to harness the power of science to drive just transformation for healthier individuals, communities, and nations.

As the Head of the Meta-research and Evidence Synthesis Unit at The George Institute for Global Health, he oversees an agile global team of researchers, specialising in using fit-for-purpose approaches for synthesising evidence to inform policies, practices, and guidelines. He is recognised internationally for his work on evidence synthesis, particularly research priority setting and core outcome sets - both its conduct and methodological aspects. He also works on the moral and epistemological aspects of meta-research in health and medicine with the intent to transform the evidence ecosystem from justice-blind to pro-justice. Soumyadeep also conducts interpretive policy analysis to understand the societal construction and framing of public health problems. As a methodologist, he works in a disease-agnostic manner, although recent work has had a focus on snakebite.

Soumyadeep' s work has impacted the way research is conducted -through the Cochrane Handbook Chapter, which provides guidance on framing the scope of systematic reviews, development of reporting guidelines for research, and through methodological research. His work routinely influences guidelines, and policies of governments and multi-laterals. They have consistently been listed as one of the top 2% lifetime cited researchers (Stanford University analysis in General & Internal Medicine and Public Health field) since 2021.

Ms Sarah Coggan is a Senior Project Manager at the George Institute for Global Health (TGI) as well as for George Clinical, TGI’s commercial partner company. She has more than 15 years of experience working in clinical trials both in the academic and commercial settings.

Sarah has a science background in Pharmacology/ Communication and a Masters of Public Health. She began employment at the George Institute in July 2012 and has remained within the Renal Program, including 2 years based remotely in the United States. Her expertise lies in the implementation of pragmatic randomised clinical trials, data linkage, building collaborative relationships with commercial and academic Sponsors, and implementing corporate knowledge within future renal research activities.

Kate has a background in Pharmacology and a PhD in the inflammatory system. She began her employment at TGI in March 2018, mainly working within the renal and metabolic division. Kate’s clinical research operations skills developed whilst working on the REDUCCTION study where she managed sites, coordinated event adjudication processes, maintained data trackers, monitored data collection, upheld ethics and research governance approvals, submitted ethics amendments, coordinated site payments, and maintained close communication with participating study sites. Her expertise has also been lent to other studies including TRIDENT (project forecasting and coordinating outcome adjudications), TRACK (unblinded team member), RESOLVE (event verification), and ATHENA (UAT). Experience has also been obtained in start-up, site initiation, site close-out, protocol and other document development, and exposure to data linkage processes.

Kate currently manages the PERFORM-AKI, ACCESS HD, DISCOVER and REVERSE studies.